Home › Researcher directory › Christophe Blanquart

Christophe Blanquart

Affiliation : Inserm · Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers · Université de Nantes · Université d'Angers · Nantes Université

• 2Publications (affiliation in France)
• 211Total publications
• 3906Citations
• 30h-index

ORCIDOpenAlex

Research profile

Christophe Blanquart has 2 indexed publications (2018–2020). Their work appears mainly in “Integrative Cancer Science and Therapeutics” and “Clinical Epigenetics”. Their most cited article, “Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma” (2018), has been cited 49 times. Their work is co-authored with at least 4 researchers, including institutions in Morocco.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Occupational and environmental lung diseases
• Histone Deacetylase Inhibitors Research
• Intraperitoneal and Appendiceal Malignancies
• Lung Cancer Treatments and Mutations
• Pharmacogenetics and Drug Metabolism

Publications (2)

• A better understanding of cancer metabolism for a more efficient immunotherapy
  2020 · Integrative Cancer Science and Therapeutics
• Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
  2018 · Clinical Epigenetics · cited 49 times

Publication venues

• Integrative Cancer Science and Therapeutics × 1
• Clinical Epigenetics × 1

Publications per year

• 20201
• 20181

Collaborations

Partner institutions : Abdelmalek Essaâdi University

Co-authors’ countries : Morocco

Co-authors

• Marc Grégoire
• Virginie Dehame
• Sophie Deshayes
• Thibaut Blondy

Bibliographic data from OpenAlex (open database).